MRI scores top marks in FDA GMP inspection

Related tags Management

The U.S. Food and Drug Administration (FDA) found no deficiencies or areas where corrective action notices following a cGMP (current Good Manufacturing Practices) inspection of its facility in Utah.

The news was greeted as a milestone for the company by Kris McDonald, quality assurance director and lab manager for MRI. The company manufactures dietary supplements using ionic minerals from Utah’s Great Salt Lake and supplies GRAS (Generally Recognized as Safe) mineral ingredients.

“The FDA inspector said that this was the first inspection where he did not issue a single write up. Obviously, we are very pleased with results of the inspection,”​ said Bruce Anderson, president/CEO of MRI.

“We feel that the outcome of this inspection speaks volumes about our company’s dedication, care, and adherence to quality standards. I am very proud of our employees who work daily to maintain high standards and continue to improve upon the efficiency, quality, and service of our company.”

The company singled out NSF International and the law offices of Jonathan Emord, Esq. for special thanks and “their valuable assistance in MRI’s preparations for this flawless audit”​.

Related topics Suppliers GMPs, QA & QC

Follow us


View more